Monkeypox outbreak 2022 - guidance

This guidance covers the pathway and clinical considerations in the following situations:
(1) care of a child or young person (CYP) with suspected monkeypox,
(2) CYP contact of a confirmed case of monkeypox,
(3) newborn baby of a mother with suspected or confirmed monkeypox.
Last modified
29 June 2022



Monkeypox virus (MPXV) is endemic in Western and Central Africa. A global outbreak is currently (from May 2022) occurring in non-endemic countries including the UK, continental Europe, Australia, Canada & the United States of America. Cases in this outbreak have mostly, but not exclusively, occurred in individuals who identify as gay, bisexual and other men who have sex with men. Monkeypox is currently classified as a High Consequence Infectious disease (HCID). It is transmitted by close physical contact with lesions (including shed skin cells in e.g. bed linen) and by respiratory droplet spread.

There is relatively little published data on monkeypox in children. In outbreaks in West and Central Africa, younger children had a higher mortality rate than adolescents and adults. It is currently thought that this risk is greatest in infants and the immunocompromised.

Further background information is available on the GOV.UK website

Case definitions

These are defined nationally by UKHSA. Please note these may change as the situation evolves - see latest definitions.

Possible case

A person with a febrile prodromeFebrile prodrome consists of fever ≥ 38°C, chills, headache, exhaustion, muscle aches (myalgia), joint pain (arthralgia), backache, and swollen lymph nodes (lymphadenopathy). compatible with monkeypox infection where there is known prior contact with a confirmed case in the 21 days before symptom onset.

Or, a person with an illness where the clinician has a high suspicion of monkeypox (for example, this may include prodrome or atypical presentations with exposure histories deemed high risk by the clinician, or classical rash without risk factors).

Probable case

A person with an unexplained rash on any part of their body plus one or more classical symptom or symptoms of monkeypox infection. Acute illness with fever (>38.5°C), intense headaches, myalgia, arthralgia, back pain, lymphadenopathy. since 15 March 2022 and either:

  • has an epidemiological link to a confirmed or probable case of monkeypox in the 21 days before symptom onset, or
  • reported a travel history to West or Central Africa in the 21 days before symptom onset, or
  • is a gay, bisexual or other man who has sex with men

Currently, it would appear to be highly unlikely that a CYP has monkeypox in the absence of one of these three epidemiological risk factors.

Clinical features

The incubation period for monkeypox is between 5 and 21 days. Monkeypox infection is usually a self-limiting illness and most people recover within several weeks. However, severe illness can occur in some individuals, with children, pregnant women and the immunosuppressed thought to be most at risk.

Classically, monkeypox begins with a prodrome with fever, headache, muscle aches, backache, swollen lymph nodes, chills and exhaustion. Within 1 to 5 days, a rash develops, often beginning on the face then spreading to other parts of the body, often the palms and soles before spreading elsewhere centrally (see pictures here and here). The rash changes and goes through different stages (macule -> papule -> vesicle -> pustule) before finally forming a scab which later falls off.

Whilst monkeypox rash often demonstrates the 4 “Ps”; Pustules, Peripheral, Palms/soles, lymPhadenopathy, not all cases will have these features. An individual is contagious until all the scabs have fallen off and there is intact skin underneath. The scabs may also contain infectious virus material.

Differential diagnoses

Common differentials for a vesicular and similar rashes in children include chickenpox, HSV, enteroviral infection and molloscum contagiosum. Classically, monkeypox lesions are all at a similar stage of maturation, unlike chickenpox where they appear over several days leading to lesions at different stages at any time. Note that this is not always the case, and monkeypox lesions can appear in crops over several days in some individuals making this distinction unreliable. Chickenpox rash typically begins centrally on the trunk and spreads peripherally. Monkeypox is classically described as beginning peripherally (face, extremities including palms and soles) and spreading centrally. Again, in the current outbreak, rashes have been atypical - sometimes more localised and often present in the genital area. Vesicular rashes of enterovirus can also be primarily peripheral such as in hand, foot and mouth disease.

In the absence of an identified epidemiological risk factor, monkeypox is exceptionally unlikely at the present time in the UK. However, in the presence of an epidemiological risk factor, any CYP with a compatible clinical picture should undergo PCR testing to rule out monkeypox.

Risks to the newborn

There is little known about monkeypox in pregnancy and risks of transmission prior to, during and following delivery. It is possible for monkeypox virus to be transmitted in utero from mother to fetus. Where this has been described in the first half of pregnancy, it has been associated with severe disease and fetal loss (Mbala, J Infect Dis 2017). The frequency with which this occurs is not known, and it is possible that the baby is born uninfected. There is also a possible risk of perinatal infection. Close contact with lesions is a recognised route of transmission (UKHSA, Monkeypox: Guidance), making vaginal delivery with monkeypox lesions a significant additional exposure risk. It is important to note that the neonate is considered to be at very high risk of severe disease if infected with monkeypox.

In an outbreak of monkeypox in the USA in 2003, paediatric patients were hospitalised in intensive care units at significantly higher rates than adults (Huhn, Clin Infect Dis 2005). The most critically ill patients in that outbreak were 2 young school-aged children with complications that included encephalopathy and retropharyngeal abscess. Several reports from outbreaks in countries in Africa note the higher incidence of mortality amongst younger children (Meyer, J Clin Microbiol 2002; Jezek & Fenner, Monogr Virol 1988) including the death in a child at one month of age (Yinka-Ogunleye, Lancet Infect Dis 2019). The high level of concern around protecting children from infection is reflected in UKHSA guidance around isolation of confirmed cases of monkeypox (UKHSA, Monkeypox: Guidance). Confirmed cases who are unable to isolate away from children in the household, are admitted to hospital to protect the child at home. 

There are to our knowledge no published reports of the outcomes of perinatal or neonatal exposure. As it is probable that newborns are at the highest level of vulnerability, it seems prudent to minimise infection risk to the new born baby.  This would include exposure risk during delivery (e.g. exposure to genital lesions) and following delivery (exposure of potentially vulnerable newborn to infectious mother or other potentially exposed/infectious members of the household). Such precautions would not be needed if there is evidence the baby is already infected (e.g. from amniocentesis or a postnatal PCR test).

There are no current data regarding risk from breast milk transmission of monkeypox. Several other viruses are transmitted to infants through breast milk (Lawrence, Breastfeeding 2011). In addition to the possible risk of the breast milk itself, there is the known additional risk from close physical contact. A case has been reported of transmission of the virus in smallpox vaccine (vaccinia, closely related to monkeypox) during breastfeeding leading to contact vaccinia in the baby (Garde, JAMA 2004). Contacts of confirmed monkeypox cases may be incubating the virus or asymptomatically infected. Their breast milk may also potentially transmit monkeypox virus. WHO advises that women in this situation do not donate breast milk.

Guidance Part A: CYP with suspected monkeypox

Please see pathway flowchart in Appendix A

1. Arrangements for clinical assessment

Staff assessing CYP with suspected monkeypox should wear personal protective equipment (PPE) in accordance with national and local guidance. 

An epidemiological risk factor may be known in advance raising suspicion of monkeypox. Where possible and safe to do so, assess the child outside healthcare premises to minimise risk of spread of infection. This may include use of repurposed COVID-19 testing pods outside hospitals. Referrals who are otherwise well should ideally be seen in such a facility where available. As an alternative, consider the possibility of a home assessment with appropriate PPE and waste disposal arrangements carefully planned in advance. Take advice from your local IPC and infection teams.

For young people over 13 years of age where sexual contact is the identified risk factor for suspected monkeypox, consider referral to a sexual health centre. This may provide opportunity for comprehensive sexual health assessment and advice, alongside testing for monkeypox. For any presentation based on sexual contact, consider whether this raises any safeguarding concerns.

If assessment outside the department is not possible, or if the patient requires assessment in the Emergency Department for other clinical reasons, precaution must be taken to prevent possible transmission of infection. Follow local guidance to isolate the child in a dedicated cubicle as soon as the risk is identified, ideally on entering the Department, if not possible in advance of arrival. If such isolation is not possible, provide patients with a fluid resistant surgical mask and cover any visible lesions (using an appropriate combination of gown, gloves and surgical cap), and remain at least 1 metre away from other people.

Staff should ensure they are wearing appropriate PPE. For possible/probable cases this includes gloves, a fluid repellent surgical facemask, and an apron. The facemask should be replaced with an FFP3 respirator and eye protection if the case presents with a lower respiratory tract infection with a cough and / or changes on their chest x-ray indicating lower respiratory tract infection. Eye protection is also required if there is a risk of splash to the face and eyes (for example when taking diagnostic tests). Follow national and local guidance around waste disposal and cleaning afterwards.

Clinical assessment of a CYP with suspected monkeypox should be performed with the least physical contact and with the fewest people that is required for safe assessment. It should be done by the most appropriately senior professionals available in appropriate PPE. Consider the use of digital photography with consent and appropriate governance to enable more specialist staff to advise on whether lesions are concerning or not.

If following assessment monkeypox is suspected and you are proceeding with testing, consider maintaining a log of staff who enter the cubicle or have contact with the patient, in case subsequent contact tracing is required.

Further advice is available from regional paediatric infectious diseases teams.

2. How to clinically assess and test for monkeypox in a child

Download a PDF of these questions below

Useful questions to ask

Questions for all:

  • When did the rash start?
  • Where did the rash begin?  Palms and soles or centrally?
  • How large are the lesions?
  • Total number of lesions? 1-10 / 10-100 / 100 +
  • Status of lesions – vesicles? scabbing over? When did last new lesion appear?
  • Any eye/mouth/genital/rectal lesions? [ask with appropriate relevance and sensitivity if young person is sexually active]
  • Any lesions causing particular concern? e.g. pain/bleeding.
  • Fever?
  • Headache?
  • Vomiting? Able to keep down fluids?
  • Diarrhoea?
  • Fatigue or lethargy?
  • Breathing difficulties?
  • Any other symptoms?
  • Do they feel they are getting better? Same? Worse?
  • Any comorbidities, and specifically immunodeficiency/immune suppression
  • Confirm address and contact details

Questions for those with a contact with a confirmed monkeypox case:

  • Note details of the exposure including time and nature

Questions for those with a travel history:

  • Countries visited with dates of arrival and departure

Questions for young people:

  • Complete psychosocial history using HEADSS tool
  • Are they sexually active?
  • If so ask about last sexual contact, ask if they are sexually active and consider asking if relevant
  • Last sexual contact?
  • High risk factors for the current outbreak are individuals who identify as MSM.

3. How to test for monkeypox in a child

Two viral swabs of skin lesions should be taken (see figure of optimal way to sample from a lesion). If the lesions are not yet vesicular/pustular and just dry macular/papular lesions, a throat swab should be taken in addition. Follow local guidance from your local virology/infection team as to how these samples should be labelled and transported. Ensure 24/7 contact details for the referring team are on the request to allow prompt communication of the result.

At the same time, further tests may be required considering alternate diagnoses, such as a further viral swab of vesicles for HSV/VZV/enterovirus PCR. Consider the need to take a bacterial culture if lesions appear secondarily infected. It is recommended that all swabs are taken at the same time to minimise risk of exposure to staff.

The optimal way to swab a vesicle/pustule is shown in the diagram below.

How to swab a vesicle for PCR - instructions

View image on full screen

4. Child with suspected monkeypox who is well enough to return home

It is important to consider how well a child can isolate whilst at home, particularly from others who may be at higher risk. This includes other children, pregnant women and the immunocompromised. Consider asking about whether they share a bedroom, and whether there is a separate bathroom/toilet they can use.

If the clinical presentation is strongly suggestive of monkeypox, and other alternative diagnoses seem highly unlikely, consider applying this more stringent level of isolation even prior to confirmation. This may lead to a decision to admit to hospital for the protection of others, particularly if home isolation is not practical.

As others in the household may be infected, they should ideally also remain at home until the result is available. This usually takes around 48 hours. This may require a risk assessment based on exposure since symptom onset.

All these situations require careful planning, with consideration of the care and emotional needs of the child and other children in the household, alongside the need to protect those at high risk.

Provide families with a copy of Appendix B: How to isolate if you are suspected of having monkeypox and contact details for your team.

It is the responsibility of the assessing team to maintain daily virtual contact with the child to monitor wellbeing and clinical progression until the result of the PCR test is available.

  • If the PCR result is positive and monkeypox confirmed, the HCID pathway will be activated by the laboratory. Arrangements for further assessment and management will be made by the national HCID network. The local Health Protection Team will commence contact tracing and provide further guidance. The team who sent the test is required to inform the patient/carer of the positive test result, and advise regarding ongoing isolation pending the decision of the HCID network meeting.
  • If the result is negative, it is the responsibility of the team who sent the test to inform the family of the result and assuming there are no other infection control concerns, advise them to end isolation.

5. Child with suspected monkeypox who requires hospital admission

Following local assessment, an unwell child who is still deemed to have suspected monkeypox may require hospital admission. In such a situation, continue to follow guidance regarding enhanced PPE, minimising staff contact with the child, and care with waste disposal. In these circumstances, local teams are advised to discuss patients with the paediatric infectious diseases teams at their nearest airborne HCID centre (see list at end of document).

Use the checklist in Appendix C to ensure you have done all that is required.

In the event that the patient is confirmed to have monkeypox, they will be automatically referred to the HCID network for ongoing care planning.

Guidance Part B: Child contacts of confirmed case of monkeypox

There is a national framework for risk assessing both the exposure and the vulnerability of the contact. Actions may include varying degrees of isolation of contacts, passive or active monitoring and eligibility for vaccination. This recognises the increased risk of more severe disease in children.

UKHSA has undertaken an assessment of the safety of Imvanex® vaccine for prevention of monkeypox. It can be used in infants and children. For children under one year of age, it is advised that a risk assessment should be undertaken in conjunction with a PID consultant prior to offering vaccination.

If an adult with confirmed monkeypox is unable to isolate away from a child in the household, this will lead to a recommendation that the adult case is admitted to hospital, following UKHSA guidance.

A child contact who is considered to have had an unprotected exposure will require active monitoring. This requires a daily assessment of wellbeing and whether any symptoms have developed.  igns/symptoms of concern include headache, fever, chills, sore throat, malaise, fatigue, rash, and lymphadenopathy. It can be performed remotely by telephone or video call. Responsibility for this monitoring is with the Health Protection Team. There may be situations where it is beneficial for a paediatric clinician to assist some elements of this, and paediatricians should be prepared to assist HPTs as required. Further support and advice is available from regional PID teams with further input from HCID paediatric clinicians.

Contacts being monitored who develop any symptom consistent with monkeypox should be considered a suspected case and be managed according to Part A of this guideline. They will require face to face assessment and possible hospital admission. This is likely to require careful planning. It may be possible to arrange a home assessment and testing. If this is not practical or clinically appropriate, admission to an HCID unit may be the most appropriate solution to maintain safety. It is recommended to involve HCID paediatric infectious diseases teams early in such discussions even prior to the diagnosis being confirmed.

Paediatric Airborne High Consequence Infectious Disease Units

Call switchboard and ask for Paediatric Infectious Disease doctor on-call.

Hospital / Trust Switchboard

Evelina London Children’s Hospital

(Guys & St Thomas’ NHS Foundation Trust)

020 7188 7188

St Mary’s Hospital, London

(Imperial College Healthcare NHS Foundation Trust)

020 3312 6666
Alder Hey Children’s NHS Foundation Trust, Liverpool 0151 228 4811
Newcastle upon Tyne Hospitals NHS Foundation Trust 0191 233 6161

Guidance Part C: Newborn baby of mother with suspected or confirmed monkeypox


This guidance pertains to the care of a newborn when the mother has suspected or proven monkeypox on the basis of a known epidemiological link and a compatible clinical syndrome; or a highly suggestive clinical syndrome without an epidemiological link.

It does not cover the more common situation of a baby born to a woman with isolated genital lesions in the absence of a known epidemiological link.


There is a relative lack of evidence to guide decision making, with concern that newborns may be at high risk of severe disease if infected. Where possible it is advised that clinical teams contact the airborne (Airborne) Network by calling the UKHSA Imported Fever Service on 0844 778 8990 to convene an urgent multidisciplinary meeting. If this has not been possible prior to delivery, this discussion should take place as soon as possible following delivery. This will allow clinicians to access the most up to date information and expert opinion to guide the mother’s decision making around these risks and how to minimise them.

The aim of this guidance is to reach an appropriate balance between the potential risk to the newborn of perinatal infection and the risks inherent in mother/baby separation.  These guidelines will be regularly reviewed to reflect new information on the balance of risk, in order to normalise bonding and feeding to the maximum degree possible.

Specialist advice is available 24/7 from Paediatric Infectious Diseases teams at HCID centres.

1. Isolation of mother and baby until maternal monkeypox status is known

A baby born to a mother with suspected or confirmed monkeypox at any stage of pregnancy or at the time of delivery, should be assumed to be infected until testing excludes infection. PPE, including protection against airborne transmission, should be worn and visitors should be appropriately restricted. It will not initially be known if the baby is infected and how this may transmit to staff. In view of this, assuming the possibility for transmission by aerosolisation, AGP PPE is advised, in line with national and local guidance.  The baby should be isolated from other babies.

The baby should be tested for Monkeypox virus by PCR from throat swab, blood, urine and swabs of any skin lesions.

The baby may be uninfected and at risk if exposed to its infectious mother.  As the risk to the baby is potentially very significant, initially the baby should be separated from the mother. If the mother tests negative, or if both mother and infant both test positive, they should be reunited (where clinically appropriate). Mothers and partners should be counselled on the risk monkeypox could pose to the baby and the rationale for separation.  If this approach remains unacceptable to them, particularly if there are factors present that are considered to reduce risk, multidisciplinary discussion should take place to identify the most appropriate way to proceed.

2. Management of baby if mother is confirmed positive

If the mother tests positive and the infant tests negative, careful planning will be required regarding mother and infant contact, considering the balance of the risk of infant infection and the importance of bonding. This will depend on several factors including maternal day of symptoms and the evolution and sites of lesions. Planning should involve a multidisciplinary team including maternity, virology, neonatology, adult and paediatric infectious diseases specialists, through the HCID network. The role of post-exposure prophylactic measures for the baby should be discussed with the HCID network.

If, at any time, the baby is also confirmed to be infected, mother and baby may be reunited where otherwise clinically appropriate. The baby will be automatically referred to the HCID network for consideration of early antiviral treatment. This may require transfer of the baby to an HCID unit for further management, ideally keeping mother and baby together.

3. Breastfeeding

Close physical contact is a known risk factor for transmission. It is not currently known whether monkeypox is transmissible via breast milk  Despite the well recognised benefits of breastfeeding, based on the current balance of risk and harm, women with suspected or confirmed monkeypox should be advised not to breastfeed until they are known not to be infectious.  Breast milk may be expressed to initiate and maintain supply until breastfeeding is considered safe. This milk is potentially infectious and should be disposed of following IPC waste disposal guidance. Where both mother and the neonate are infected, breastfeeding should be supported.

Donor breast milk can be considered in place of formula feeding, until maternal breast milk is deemed safe. Asymptomatic contacts of a confirmed case of monkeypox should not donate breast milk until they are no longer considered potentially infected.

Appendix A: Monkeypox in children & young people - quick guide

Download a PDF of this flowchart below (Appendix A - quick guide flowchart).


RCPCH monkeypox guidance flowchart

Appendix B: How to isolate if you are suspected of having monkeypox

Download a PDF of this guidance below

Please return straight home. 

The person with suspected monkeypox should wear a mask and cover all skin lesions.

  • Isolate if possible in a room separate from other household members
  • Where not possible aim to keep 1 metre away from others and avoid all skin to skin contact.
  • If possible, use a different bathroom to other household members.
  • Non-household members should not visit the residence.
  • Avoid any physical contacts. 
  • Do not leave the residence.
  • Pets should be excluded from infected person’s environment.
  • If contact with other household members is unavoidable – all should wear surgical masks and skin lesions should be covered.
  • Maintain good hand hygiene with soap and water.
  • Linen and towels should not be shared.
  • Avoid shaking used laundry to prevent dispersing of infectious particles.
  • Dishes and utensils can be cleaned with soap and water.
  • Contaminated surfaces should be cleaned with alcohol or chlorine-based household disinfectants.
  • If possible, take photographs of the rash as it evolves day by day - your doctor will advise on how to send these

Your hospital team will maintain contact with you to check on your / your child’s progress.

Should you need to contact the hospital, please call [enter phone number] and ask for [enter name/team].

Appendix C: Actions when admitting a child with suspected monkeypox

Download a PDF of this checklist below

Task Mark when completed
Allocate cubicle with en suite or commode (negative pressure if available, otherwise neutral)  
Inform IPC team - plan waste disposal  
Put up signage about No entry and need for appropriate PPE  
Ensure supply of PPE available  
Start a log of entry/exit to the room  
Inform paediatric consultant  

Discuss with HCID paediatric infectious disease team (one of Evelina / St Marys / Newcastle / Alder Hey - see contacts above)

Working group members

  • PID - Paediatric Infectious Diseases
  • HCID - High Consequence Infectious Disease
  • BPAIIG - British Paediatric Allergy, Immunology & Infection Group
  • BAPM - British Association for Perinatal Medicine

CYP guidance working group

Johnathan Cohen (Chair) Consultant in PID, Evelina London Children's Hospital (HCID Unit)
Liz Whittaker Consultant in PID, Imperial College Healthcare - St Marys Hospital, London (HCID Unit) 
Convener, BPAIIG
Alasdair Bamford

Consultant in PID, Great Ormond Street Hospital, London
Secretary, BPAIIG

Bhanu Williams Consultant General Paediatrician with PID Expertise, Northwick Park Hospital, London
Sarah Eisen Consultant General Paediatrician with PID Expertise, University College London Hospital
Marieke Emonts Consultant in PID, Great North Children's Hospital, Newcastle (HCID Unit)
Hermione Lyall Consultant in PID, Imperial College Healthcare - St Marys Hospital, London (HCID Unit)
David Porter

Consultant in PID, Alder Hey Hospital, Liverpool (HCID Unit)
Treasurer, BPAIIG

Andrew Riordan Consultant in PID, Alder Hey Hospital, Liverpool (HCID Unit)
David Ho Consultant in PID, Evelina London Children's Hospital (HCID Unit)
Seilesh Kadambari Consultant in PID, Great Ormond Street Hospital, London

Newborn guidance working group

Jonathan Cohen (Chair) Consultant in PID, Evelina London Children's Hospital (HCID Unit)
Liz Whittaker Consultant in PID, Imperial College Healthcare - St Marys Hospital, London (HCID Unit)
Convenor, BPAIIG
Alasdair Bamford Consultant in PID, Great Ormond Street Hospital, London
Secretary, BPAIIG<
Richard Hearn Consultant Neonatologist, Newcastle-upon-Tyne Hospitals (HCID Unit)
Helen Mactier Consultant Neonatologist, Princess Royal Maternity Hospital, Glasgow
President (BAPM)
Marieke Emonts Consultant in PID, Great North Children's Hospital - St Marys Hospital, London (HCID Unit)
Hermione Lyall Consultant in PID, Imperial College Healthcare - St Marys Hospital, London (HCID Unit)
David Porter Consultant in PID, Alder Hey Hospital, Liverpool (HCID Unit)
Treasurer, BPAIIG<
Andrew Riordan Consultant in PID, Alder Hey Hospital, Liverpool (HCID Unit)
Benjamin Black Consultant Obstetrician and Gynaecologist, Whittington Hospital, London